tiprankstipranks
Trending News
More News >
Illumina (ILMN)
NASDAQ:ILMN
US Market

Illumina (ILMN) Stock Forecast & Price Target

Compare
4,428 Followers
See the Price Targets and Ratings of:

ILMN Analyst Ratings

Moderate Buy
17Ratings
Moderate Buy
8 Buy
7 Hold
2 Sell
Based on 17 analysts giving stock ratings to
Illumina
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ILMN Stock 12 Month Forecast

Average Price Target

$107.13
▲(28.82%Upside)
Based on 17 Wall Street analysts offering 12 month price targets for Illumina in the last 3 months. The average price target is $107.13 with a high forecast of $185.00 and a low forecast of $75.00. The average price target represents a 28.82% change from the last price of $83.16.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"74":"$74","102":"$102","130":"$130","158":"$158","186":"$186"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":185,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$185.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":107.13,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$107.13</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":75,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$75.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[74,102,130,158,186],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2024","6":"Nov<br/>2024","9":"Feb<br/>2025","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,76.51,84.85538461538462,93.20076923076924,101.54615384615386,109.89153846153846,118.23692307692309,126.5823076923077,134.92769230769233,143.27307692307693,151.61846153846153,159.96384615384616,168.3092307692308,176.6546153846154,{"y":185,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,76.51,78.86538461538461,81.22076923076924,83.57615384615384,85.93153846153847,88.28692307692307,90.6423076923077,92.9976923076923,95.35307692307693,97.70846153846153,100.06384615384616,102.41923076923077,104.77461538461537,{"y":107.13,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,76.51,76.39384615384616,76.2776923076923,76.16153846153847,76.04538461538462,75.92923076923077,75.81307692307692,75.69692307692308,75.58076923076923,75.46461538461539,75.34846153846154,75.2323076923077,75.11615384615385,{"y":75,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":121.17,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":101.34,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":105.5,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":122.35,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":131.4,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":128.98,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":149.76,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":145.15,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":133.63,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":132.74,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":88.74,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 9</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":78.39,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 10</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":76.51,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$185.00Average Price Target$107.13Lowest Price Target$75.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on ILMN
TipRanks AITipRanks
Not Ranked
TipRanks
$84
Hold
1.01%
Upside
Reiterated
06/05/25
Illumina's stock score reflects significant financial challenges due to operational inefficiencies and declining revenues, despite strong gross margins. Technical analysis provides mixed signals with short-term bullish momentum but long-term bearish trends. The company's valuation is weak due to a negative P/E ratio, underscoring the need for financial improvement. Earnings call highlights some promising developments, but geopolitical and economic headwinds pose substantial risks.
Stifel Nicolaus Analyst forecast on ILMN
Daniel AriasStifel Nicolaus
Stifel Nicolaus
$135
Buy
62.34%
Upside
Reiterated
05/28/25
Illumina (ILMN) Receives a Buy from Stifel Nicolaus
Leerink Partners Analyst forecast on ILMN
Puneet SoudaLeerink Partners
Leerink Partners
Buy
Reiterated
05/27/25
Illumina: Strong Market Position and Value Opportunity Amidst Emerging Competition
Stephens Analyst forecast on ILMN
Unknown AnalystStephens
Not Ranked
Stephens
$105
Buy
26.26%
Upside
Reiterated
05/20/25
Piper Sandler Analyst forecast on ILMN
David WestenbergPiper Sandler
Piper Sandler
$190$185
Buy
122.46%
Upside
Reiterated
05/15/25
Piper Sandler Reaffirms Their Buy Rating on Illumina (ILMN)
UBS
$145$98
Hold
17.85%
Upside
Reiterated
05/14/25
Illumina price target lowered to $98 from $145 at UBSIllumina price target lowered to $98 from $145 at UBS
Morgan Stanley Analyst forecast on ILMN
Tejas SavantMorgan Stanley
Morgan Stanley
$100
Hold
20.25%
Upside
Reiterated
05/12/25
Illumina's Hold Rating Amidst Strong Instrument Sales and Challenges in Chinese Market
Canaccord Genuity Analyst forecast on ILMN
Kyle Mikson CFACanaccord Genuity
Canaccord Genuity
$92$87
Hold
4.62%
Upside
Reiterated
05/12/25
Illumina price target lowered to $87 from $92 at CanaccordIllumina price target lowered to $87 from $92 at Canaccord
TD Cowen
$86$89
Hold
7.02%
Upside
Reiterated
05/09/25
TD Cowen Reaffirms Their Hold Rating on Illumina (ILMN)
J.P. Morgan Analyst forecast on ILMN
Rachel VatnsdalJ.P. Morgan
J.P. Morgan
$120$85
Hold
2.21%
Upside
Reiterated
05/09/25
Illumina price target lowered to $85 from $120 at JPMorganIllumina price target lowered to $85 from $120 at JPMorgan
Guggenheim Analyst forecast on ILMN
Subbu NambiGuggenheim
Guggenheim
$122$114
Buy
37.09%
Upside
Reiterated
05/09/25
Illumina price target lowered to $114 from $122 at GuggenheimIllumina price target lowered to $114 from $122 at Guggenheim
Barclays Analyst forecast on ILMN
Luke SergottBarclays
Barclays
$77
Sell
-7.41%
Downside
Reiterated
05/09/25
Barclays Remains a Sell on Illumina (ILMN)
RBC Capital Analyst forecast on ILMN
Conor McNamaraRBC Capital
RBC Capital
$112
Buy
34.68%
Upside
Reiterated
05/09/25
RBC Capital Remains a Buy on Illumina (ILMN)
Citi
$85
Hold
2.21%
Upside
Reiterated
05/08/25
Illumina's Financial Outlook: Hold Rating Amidst Export Bans and Tariff Challenges
Bernstein Analyst forecast on ILMN
Eve BursteinBernstein
Bernstein
Hold
Reiterated
05/05/25
Analysts Offer Insights on Healthcare Companies: Janux Therapeutics Inc (NASDAQ: JANX) and Illumina (NASDAQ: ILMN)
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on ILMN
TipRanks AITipRanks
Not Ranked
TipRanks
$84
Hold
1.01%
Upside
Reiterated
06/05/25
Illumina's stock score reflects significant financial challenges due to operational inefficiencies and declining revenues, despite strong gross margins. Technical analysis provides mixed signals with short-term bullish momentum but long-term bearish trends. The company's valuation is weak due to a negative P/E ratio, underscoring the need for financial improvement. Earnings call highlights some promising developments, but geopolitical and economic headwinds pose substantial risks.
Stifel Nicolaus Analyst forecast on ILMN
Daniel AriasStifel Nicolaus
Stifel Nicolaus
$135
Buy
62.34%
Upside
Reiterated
05/28/25
Illumina (ILMN) Receives a Buy from Stifel Nicolaus
Leerink Partners Analyst forecast on ILMN
Puneet SoudaLeerink Partners
Leerink Partners
Buy
Reiterated
05/27/25
Illumina: Strong Market Position and Value Opportunity Amidst Emerging Competition
Stephens Analyst forecast on ILMN
Unknown AnalystStephens
Not Ranked
Stephens
$105
Buy
26.26%
Upside
Reiterated
05/20/25
Piper Sandler Analyst forecast on ILMN
David WestenbergPiper Sandler
Piper Sandler
$190$185
Buy
122.46%
Upside
Reiterated
05/15/25
Piper Sandler Reaffirms Their Buy Rating on Illumina (ILMN)
UBS
$145$98
Hold
17.85%
Upside
Reiterated
05/14/25
Illumina price target lowered to $98 from $145 at UBSIllumina price target lowered to $98 from $145 at UBS
Morgan Stanley Analyst forecast on ILMN
Tejas SavantMorgan Stanley
Morgan Stanley
$100
Hold
20.25%
Upside
Reiterated
05/12/25
Illumina's Hold Rating Amidst Strong Instrument Sales and Challenges in Chinese Market
Canaccord Genuity Analyst forecast on ILMN
Kyle Mikson CFACanaccord Genuity
Canaccord Genuity
$92$87
Hold
4.62%
Upside
Reiterated
05/12/25
Illumina price target lowered to $87 from $92 at CanaccordIllumina price target lowered to $87 from $92 at Canaccord
TD Cowen
$86$89
Hold
7.02%
Upside
Reiterated
05/09/25
TD Cowen Reaffirms Their Hold Rating on Illumina (ILMN)
J.P. Morgan Analyst forecast on ILMN
Rachel VatnsdalJ.P. Morgan
J.P. Morgan
$120$85
Hold
2.21%
Upside
Reiterated
05/09/25
Illumina price target lowered to $85 from $120 at JPMorganIllumina price target lowered to $85 from $120 at JPMorgan
Guggenheim Analyst forecast on ILMN
Subbu NambiGuggenheim
Guggenheim
$122$114
Buy
37.09%
Upside
Reiterated
05/09/25
Illumina price target lowered to $114 from $122 at GuggenheimIllumina price target lowered to $114 from $122 at Guggenheim
Barclays Analyst forecast on ILMN
Luke SergottBarclays
Barclays
$77
Sell
-7.41%
Downside
Reiterated
05/09/25
Barclays Remains a Sell on Illumina (ILMN)
RBC Capital Analyst forecast on ILMN
Conor McNamaraRBC Capital
RBC Capital
$112
Buy
34.68%
Upside
Reiterated
05/09/25
RBC Capital Remains a Buy on Illumina (ILMN)
Citi
$85
Hold
2.21%
Upside
Reiterated
05/08/25
Illumina's Financial Outlook: Hold Rating Amidst Export Bans and Tariff Challenges
Bernstein Analyst forecast on ILMN
Eve BursteinBernstein
Bernstein
Hold
Reiterated
05/05/25
Analysts Offer Insights on Healthcare Companies: Janux Therapeutics Inc (NASDAQ: JANX) and Illumina (NASDAQ: ILMN)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Illumina

1 Month
xxx
Success Rate
14/25 ratings generated profit
56%
Average Return
+1.04%
reiterated a xxx
rating 28 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 56.00% of your transactions generating a profit, with an average return of +1.04% per trade.
3 Months
xxx
Success Rate
14/25 ratings generated profit
56%
Average Return
+2.00%
reiterated a xxx
rating 28 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 56.00% of your transactions generating a profit, with an average return of +2.00% per trade.
1 Year
Doug SchenkelWolfe Research
Success Rate
23/32 ratings generated profit
72%
Average Return
+15.33%
reiterated a buy rating 3 months ago
Copying Doug Schenkel's trades and holding each position for 1 Year would result in 71.88% of your transactions generating a profit, with an average return of +15.33% per trade.
2 Years
xxx
Success Rate
18/25 ratings generated profit
72%
Average Return
+11.34%
reiterated a xxx
rating 28 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 72.00% of your transactions generating a profit, with an average return of +11.34% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ILMN Analyst Recommendation Trends

Rating
Jan 25
Feb 25
Mar 25
Apr 25
May 25
Strong Buy
3
6
15
18
20
Buy
12
6
8
6
6
Hold
11
15
22
22
20
Sell
1
5
9
10
7
Strong Sell
0
0
0
0
0
total
27
32
54
56
53
In the current month, ILMN has received 26 Buy Ratings, 20 Hold Ratings, and 7 Sell Ratings. ILMN average Analyst price target in the past 3 months is 107.13.
Each month's total comprises the sum of three months' worth of ratings.

ILMN Financial Forecast

ILMN Earnings Forecast

Next quarter’s earnings estimate for ILMN is $1.01 with a range of $0.97 to $1.04. The previous quarter’s EPS was $0.97. ILMN beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.04% of the time in the same period. In the last calendar year ILMN has Outperformed its overall industry.
Next quarter’s earnings estimate for ILMN is $1.01 with a range of $0.97 to $1.04. The previous quarter’s EPS was $0.97. ILMN beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.04% of the time in the same period. In the last calendar year ILMN has Outperformed its overall industry.

ILMN Sales Forecast

Next quarter’s sales forecast for ILMN is $1.05B with a range of $1.04B to $1.06B. The previous quarter’s sales results were $1.04B. ILMN beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.51% of the time in the same period. In the last calendar year ILMN has Outperformed its overall industry.
Next quarter’s sales forecast for ILMN is $1.05B with a range of $1.04B to $1.06B. The previous quarter’s sales results were $1.04B. ILMN beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.51% of the time in the same period. In the last calendar year ILMN has Outperformed its overall industry.

ILMN Stock Forecast FAQ

What is ILMN’s average 12-month price target, according to analysts?
Based on analyst ratings, Illumina’s 12-month average price target is 107.13.
    What is ILMN’s upside potential, based on the analysts’ average price target?
    Illumina has 28.82% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is ILMN a Buy, Sell or Hold?
          Illumina has a consensus rating of Moderate Buy which is based on 8 buy ratings, 7 hold ratings and 2 sell ratings.
            What is Illumina’s price target?
            The average price target for Illumina is 107.13. This is based on 17 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $185.00 ,the lowest forecast is $75.00. The average price target represents 28.82% Increase from the current price of $83.16.
              What do analysts say about Illumina?
              Illumina’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 17 Wall Streets Analysts.
                How can I buy shares of ILMN?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis